Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSIMERTINIB vs OXACILLIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSIMERTINIB vs OXACILLIN: Safety Overview

Metric OSIMERTINIB OXACILLIN
Total FAERS Reports 27,750 538
Deaths Reported 12,456 89
Death Rate 44.9% 16.5%
Hospitalizations 5,277 254
Average Patient Age 68.2 yrs 46.9 yrs
% Female Patients 66.0% 44.9%
FDA Approval Date Nov 13, 2015 Approved Prior to Jan 1, 1982
Manufacturer AstraZeneca Pharmaceuticals LP Eugia US LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued